Gujarat Kidney IPO Allotment Today: How to check status on NSE, BSE and MUFG Intime

Gujarat Kidney IPO: The initial public offering (IPO) of Gujarat Kidney and Super Speciality Limited closed for subscription on December 24, 2025, with an overall subscription of 5.21 times on the net offer. The basis of allotment of the IPO shares is likely to be finalised today, December 26.

Once the status is finalised, investors can then check their allotment status online on the websites of BSE and NSE, or the issue registrar, MUFG Intime India.

Here's a step-by-step guide on how you can check your allotment status online through the direct links:

Add Zee Business as a Preferred Source

Gujarat Kidney IPO allotment status on NSE

1) Visit the NSE website:- www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

2) Select 'Equity and SME IPO bid details'

3) Choose 'GKSL' from the dropdown list

4) Enter your PAN and application number

5) Click submit

Gujarat Kidney IPO allotment status on BSE

1) Go to the BSE website:- www.bseindia.com/investors/appli_check.aspx

2) Select 'Equity' under issue type

3) Choose 'Gujarat Kidney and Super Speciality Limited'

4) Enter your application number or PAN

5) Click search to view your allotment status

Also Read:

Gujarat Kidney IPO allotment status on MUFG Intime India

1) Visit the MUFG Intime India website:- in.mpms.mufg.com/Initial_Offer/public-issues.html

2) Select the company name from the dropdown menu

3) Enter your PAN, application number, or demat account details

4) Click submit

Gujarat Kidney IPO subscription highlights

Overall, investors bid for 6.89 crore shares against the total shares on offer. The subscription includes bids from institutional buyers, investors and retailers who booked the issue 1.06, 5.73 times and 19.04 times against their allotted portions, respectively.

About Gujarat Kidney and Super Speciality Limited

Gujarat Kidney and Super Speciality operates seven mid-sized multi-speciality hospitals across Gujarat, with a total capacity of 490 beds. The company focuses on secondary and tertiary care services.

For FY25, the company reported revenue of Rs 40.24 crore and a net profit of Rs 9.5 crore, highlighting steady financial performance.